Résumé
Managing robotic total mesorectal excision (RTME) using an enhanced recovery after surgery (ERAS) programme in patients with rectal cancer decreased overall costs compared with RTME alone. The combination significantly decreased operating time, duration of hospital stay and global morbidity compared with RTME and laparoscopic total mesorectal excision alone.
ERAS and robotic proctectomy for rectal cancer